SCOPUS 정보 검색 플랫폼

Annals of Oncology

Volumn 16, Issue 10, 2005, Pages 1567-1568

Doing cancer trials in India: Opportunities and pitfalls

(1) Raina, Vinod a

a INSTITUTE ROTARY CANCER HOSPITAL (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; G4N; LETROZOLE; M4N; NEW DRUG; UNCLASSIFIED DRUG; VORICONAZOLE;

CANCER INCIDENCE; CANCER RESEARCH; CLINICAL TRIAL; DEVELOPING COUNTRY; DRUG APPROVAL; DRUG COST; DRUG INDUSTRY; DRUG RESEARCH; ECONOMIC EVALUATION; EDITORIAL; GOVERNMENT; HUMAN; INDIA; MALIGNANT NEOPLASTIC DISEASE; PATENT; PRIORITY JOURNAL; RESEARCH ETHICS; SAMPLING; TREATMENT INDICATION;

ANTINEOPLASTIC AGENTS; CANCER CARE FACILITIES; CLINICAL TRIALS; COMMUNITY NETWORKS; DRUG INDUSTRY; HUMANS; INCIDENCE; INDIA; NEOPLASMS; RESEARCH DESIGN; SCIENTIFIC MISCONDUCT;

EID: 27144522111 PISSN: 09237534 EISSN: 15698041 Source Type: Journal
DOI: 10.1093/annonc/mdi315 Document Type: Editorial

Times cited : (4)

References (11)

1
- 27144548101
- Two year report of the population based cancer registries 1999-2000
- National Cancer Registry Program (NCRP-ICMR). Bangalore: NCRP
- National Cancer Registry Program (NCRP-ICMR). Two year report of the population based cancer registries 1999-2000; Bangalore: NCRP 2005.
- (2005)

2
- 27144496750
- Cancer research in the developing world
- 41st Annual Meeting of ASCO Educational book
- Sledge GW. Cancer research in the developing world. 41st Annual Meeting of ASCO 2005. Educational book, pp. 671-698.
- (2005) , pp. 671-698
- Sledge, G.W.¹

3
- 17244367345
- A new colonialism? Conducting clinical trials in India
- Nundy S, Gulhati M. A new colonialism? Conducting clinical trials in India. N Engl J Med 2005; 352: 1633-1636.
- (2005) N. Engl. J. Med. , vol.352 , pp. 1633-1636
- Nundy, S.¹ Gulhati, M.²

4
- 0031217649
- Research methods in cancer: Clinical trials, epidemiology and audit, Tata Memorial Hospital Mumbai
- Mani H, Pai SA. Research methods in cancer: Clinical trials, epidemiology and audit, Tata Memorial Hospital Mumbai. Natl Med J India 1997; 10: 249-250.
- (1997) Natl. Med. J. India , vol.10 , pp. 249-250
- Mani, H.¹ Pai, S.A.²

5
- 0036898202
- Standard protocol helps improve ALL survival rates in India
- Sharma DC. Standard protocol helps improve ALL survival rates in India. Lancet Oncol 2002; 3: 710.
- (2002) Lancet Oncol. , vol.3 , pp. 710
- Sharma, D.C.¹

6
- 18044400179
- Indian doctors defend "unethical" anticancer drug trial
- Mudur G. Indian doctors defend "unethical" anticancer drug trial. BMJ 2001; 323: 299.
- (2001) BMJ , vol.323 , pp. 299
- Mudur, G.¹

7
- 17944362134
- Clinical research. Hopkins reviews investment in Indian cancer drug trial
- Bagla P, Marshall E. Clinical research. Hopkins reviews investment in Indian cancer drug trial. Science 2001; 293: 1024.
- (2001) Science , vol.293 , pp. 1024
- Bagla, P.¹ Marshall, E.²

8
- 20144386702
- Indian regulations fail to monitor growing stem-cell use in clinics
- Jayaram KS. Indian regulations fail to monitor growing stem-cell use in clinics. Nature 2005; 434: 259.
- (2005) Nature , vol.434 , pp. 259
- Jayaram, K.S.¹

9
- 0035964920
- Clinical research. India acts on flawed cancer drug trials
- Bagla P. Clinical research. India acts on flawed cancer drug trials. Science 2001; 293: 2371-2373.
- (2001) Science , vol.293 , pp. 2371-2373
- Bagla, P.¹

10
- 0035213615
- Use of new cancer drugs in India
- Pal SK. Use of new cancer drugs in India. Lancet Oncol 2001; 2: 716.
- (2001) Lancet Oncol. , vol.2 , pp. 716
- Pal, S.K.¹

11
- 22144441433
- Social responsibility in cancer prevention research: IARC as a 'Global Science Force'
- Vainio H. Social responsibility in cancer prevention research: IARC as a 'Global Science Force'. Asian Pac J Cancer Prev 2002; 3: 267-272.
- (2002) Asian Pac. J. Cancer Prev. , vol.3 , pp. 267-272
- Vainio, H.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.